545 related articles for article (PubMed ID: 30670443)
21. Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia.
Chen X; Othus M; Wood BL; Walter RB; Becker PS; Percival ME; Abkowitz JL; Appelbaum FR; Estey EH
Leuk Lymphoma; 2021 May; 62(5):1226-1233. PubMed ID: 33345655
[TBL] [Abstract][Full Text] [Related]
22. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
[TBL] [Abstract][Full Text] [Related]
23. Evolution of clonal cytogenetic abnormalities in aplastic anemia.
Maciejewski JP; Selleri C
Leuk Lymphoma; 2004 Mar; 45(3):433-40. PubMed ID: 15160903
[TBL] [Abstract][Full Text] [Related]
24. Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome.
Karantanos T; DeZern AE
Best Pract Res Clin Haematol; 2021 Jun; 34(2):101280. PubMed ID: 34404534
[TBL] [Abstract][Full Text] [Related]
25. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
26. Aplastic anemia and clonal evolution: germ line and somatic genetics.
Shimamura A
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):74-82. PubMed ID: 27913465
[TBL] [Abstract][Full Text] [Related]
27. Evidence for clonal disease by magnetic resonance imaging in patients with hypoplastic marrow disorders.
Negendank W; Weissman D; Bey TM; de Planque MM; Karanes C; Smith MR; Ratanatharathorn V; Bishop CR; al-Katib AM; Sensenbrenner LL
Blood; 1991 Dec; 78(11):2872-9. PubMed ID: 1954375
[TBL] [Abstract][Full Text] [Related]
28. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
Găman M; Vlădăreanu AM; Radesi S
Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
[TBL] [Abstract][Full Text] [Related]
29. Myelodysplastic syndromes and overlap syndromes.
Chang YH
Blood Res; 2021 Apr; 56(S1):S51-S64. PubMed ID: 33935036
[TBL] [Abstract][Full Text] [Related]
30. A high occurrence of acquisition and/or expansion of C-CBL mutant clones in the progression of high-risk myelodysplastic syndrome to acute myeloid leukemia.
Kao HW; Sanada M; Liang DC; Lai CL; Lee EH; Kuo MC; Lin TL; Shih YS; Wu JH; Huang CF; Ogawa S; Shih LY
Neoplasia; 2011 Nov; 13(11):1035-42. PubMed ID: 22131879
[TBL] [Abstract][Full Text] [Related]
31. Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis.
Rauw J; Wells RA; Chesney A; Reis M; Zhang L; Buckstein R
Leuk Res; 2011 Oct; 35(10):1335-8. PubMed ID: 21704372
[TBL] [Abstract][Full Text] [Related]
32. Border between aplastic anemia and myelodysplastic syndrome.
Yamazaki H; Nakao S
Int J Hematol; 2013 May; 97(5):558-63. PubMed ID: 23613266
[TBL] [Abstract][Full Text] [Related]
33. Speaking a common language in MDS/MPNs.
Steensma DP
Blood; 2015 Mar; 125(12):1849-51. PubMed ID: 25792730
[TBL] [Abstract][Full Text] [Related]
34. Apoptotic index by Annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes.
Merchant SH; Gonchoroff NJ; Hutchison RE
Cytometry; 2001 Feb; 46(1):28-32. PubMed ID: 11241504
[TBL] [Abstract][Full Text] [Related]
35. Traipsing Through Muddy Waters: A Critical Review of the Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes.
Kuykendall AT; Tokumori FC; Komrokji RS
Hematol Oncol Clin North Am; 2021 Apr; 35(2):337-352. PubMed ID: 33641873
[TBL] [Abstract][Full Text] [Related]
36. Hypoplastic form of myelodysplastic neoplasm.
Votavová H; Lenertová Z; Votava T; Beličková M
Klin Onkol; 2023; 36(3):206-214. PubMed ID: 37353349
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium.
Nakano TA; Lau BW; Dickerson KE; Wlodarski M; Pollard J; Shimamura A; Hofmann I; Sasa G; Elghetany T; Cada M; Dror Y; Ding H; Allen SW; Hanna R; Campbell K; Olson TS
Pediatr Blood Cancer; 2020 Oct; 67(10):e28652. PubMed ID: 32779892
[TBL] [Abstract][Full Text] [Related]
38. [Genomic aberrations in myelodysplastic syndromes and related disorders].
Makishima H
Rinsho Ketsueki; 2019; 60(6):600-609. PubMed ID: 31281151
[TBL] [Abstract][Full Text] [Related]
39. An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults.
Savona MR; Malcovati L; Komrokji R; Tiu RV; Mughal TI; Orazi A; Kiladjian JJ; Padron E; Solary E; Tibes R; Itzykson R; Cazzola M; Mesa R; Maciejewski J; Fenaux P; Garcia-Manero G; Gerds A; Sanz G; Niemeyer CM; Cervantes F; Germing U; Cross NC; List AF;
Blood; 2015 Mar; 125(12):1857-65. PubMed ID: 25624319
[TBL] [Abstract][Full Text] [Related]
40. [Panmyelopathy and myeloproliferative syndrome].
Jorke D; Bach G
Z Gesamte Inn Med; 1986 Nov; 41(21):595-8. PubMed ID: 3469815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
